Catalyst Wire Dossier Catalyst Wire Dossier

Tazorac Cream 0.1%

tazarotene · Allergan
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tazorac Cream 0.1%, covering 2011-10-31 to 2012-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris [Phase 4]

See pricing